DT Investment Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-610
Closed -$54.9K 548
2025
Q4
$54.9K Hold
610
﹤0.01% 243
2025
Q3
$60.1K Hold
610
0.01% 223
2025
Q2
$55.6K Hold
610
0.01% 223
2025
Q1
$69K Hold
610
0.01% 206
2024
Q4
$64.4K Hold
610
0.01% 216
2024
Q3
$65.8K Hold
610
0.01% 224
2024
Q2
$66.2K Sell
610
-1
-0.2% -$118 0.01% 216
2024
Q1
$80.6K Buy
611
+1
+0.2% +$125 0.01% 192
2023
Q4
$74.6K Hold
610
0.01% 193
2023
Q3
$68.5K Hold
610
0.01% 183
2023
Q2
$80.7K Hold
610
0.01% 178
2023
Q1
$84.7K Hold
610
0.01% 177
2022
Q4
$77.8K Hold
610
0.01% 177
2022
Q3
$64K Buy
+610
New +$66.9K 0.01% 188

Other funds holding ZBH

DT Investment Partners's ZBH Position: Q1 2026 in Review

DT Investment Partners sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 610 shares — an estimated $54.9K sold.

DT Investment Partners first reported a position in ZBH in Q3 2022 and held it in 14 quarters. The position peaked at $84.7K in Q1 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • DT Investment Partners reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • DT Investment Partners sold 610 Zimmer Biomet shares in Q1 2026, an estimated $54.9K.
  • DT Investment Partners first reported a position in Zimmer Biomet in Q3 2022 and held it in 14 quarters.
  • DT Investment Partners's Zimmer Biomet position peaked at $84.7K in Q1 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on DT Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.